Download PDF
Twilio > Case Studies > Fred IT Group's ePrescriptions Platform: A Revolution in Medication Management
Twilio Logo

Fred IT Group's ePrescriptions Platform: A Revolution in Medication Management

Technology Category
  • Application Infrastructure & Middleware - Data Exchange & Integration
  • Platform as a Service (PaaS) - Application Development Platforms
Applicable Industries
  • Electronics
  • Life Sciences
Applicable Functions
  • Product Research & Development
Services
  • System Integration
The Challenge
Fred IT Group, a technology provider to the pharmacy industry, was tasked with transitioning the medical industry from paper to electronic prescriptions. In 2020, the company was working to make ePrescriptions a legal option for prescribing medication in Australia. They had a six-month timeline to design and build out the new platform. The challenge was to centralise the process by enabling the technology and connecting all the various 50-60 industry vendors to the eRx platform, as well as getting everyone onboard to the new system. However, the Covid-19 pandemic forced the Australian government to request that ePrescriptions become a reality in eight weeks versus six months. Fred IT Group had to find a reliable solution to meet this new deadline.
About The Customer
Fred IT Group is a technology provider to the pharmacy industry that began in the garage of two men 29 years ago. In 2009, they started the process of helping the medical industry transition from paper to electronic prescriptions with the creation of eRx Script Exchange. They have helped dispense a cumulative 3.5 billion prescriptions, which comprised approximately 90% of the prescriptions dispensed in Australia. In 2020, they were working to make ePrescriptions a legal option for prescribing medication in Australia. They were working with the Australian Digital Health Agency, The Australian Department of Health and other health industry providers to centralise the process.
The Solution
Fred IT Group turned to Twilio for the most reliable solutions to ensure they could meet the new deadline. They launched the new platform based on Twilio’s technologies and APIs. The new system works in several ways, all leveraging Twilio’s messaging platforms. The first is the token model that comes in the form of a QR-code which is provided to the patient via SMS or email. The second is My Script List (MySL) which allows patients to provide consent to their doctors, pharmacies, and other 3rd party medical organisations to access their personal list of active prescriptions available for dispense. Both the token model, and MySL, utilise the Twilio Programmable Messaging platform. Additionally, Fred IT has launched a solution to enable quick and easy SMS communications between the patient and the pharmacy. They chose Twilio’s WhatsApp for Business API to power this new feature, making it even easier for patients to manage their ePrescriptions.
Operational Impact
  • The new ePrescription platform has revolutionised the way prescriptions are managed in Australia. It has made the process safer, easier, and more effective for all Australians. The platform has not only enabled the transition from paper to electronic prescriptions but also made it possible to centralise the process by connecting all the various industry vendors to the eRx platform. The platform has also made it easier for patients to manage their ePrescriptions by enabling quick and easy SMS communications between the patient and the pharmacy. The success of the platform has positioned Fred IT Group to continue growing the new system into a fully accepted nationwide solution.
Quantitative Benefit
  • Over eleven million ePrescriptions have been created across Australia
  • 21,000 doctors and 95% of pharmacies have prescribed and dispensed an ePrescription through the new platform
  • More than six million messages have been routed through Twilio’s Programmable Messaging platform

Related Case Studies.

Contact us

Let's talk!

* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.